Home › Companies › UNITED THERAPEUTICS CORP. › 2023-2024
Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies
These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Christopher Causey | 32,655,777 | 5,007,451 | 23,624 | -- | 899,233 | Majority: yes |
| Elect Director: Raymond Dwek | 34,539,331 | 3,124,020 | 23,501 | -- | 899,233 | Majority: yes |
| Elect Director: Richard Giltner | 35,926,944 | 1,735,495 | 24,413 | -- | 899,233 | Majority: yes |
| Elect Director: Ray Kurzweil | 34,881,879 | 2,780,367 | 24,606 | -- | 899,233 | Majority: yes |
| Elect Director: Jan Malcolm | 37,494,516 | 166,925 | 25,411 | -- | 899,233 | Majority: yes |
| Elect Director: Linda Maxwell | 37,281,239 | 380,261 | 25,352 | -- | 899,233 | Majority: yes |
| Elect Director: Nilda Mesa | 36,692,631 | 968,800 | 25,421 | -- | 899,233 | Majority: yes |
| Elect Director: Judy Olian | 37,346,987 | 314,603 | 25,262 | -- | 899,233 | Majority: yes |
| Elect Director: Christopher Patusky | 33,657,384 | 4,005,882 | 23,586 | -- | 899,233 | Majority: yes |
| Elect Director: Martine Rothblatt | 35,207,735 | 2,456,733 | 22,384 | -- | 899,233 | Majority: yes |
| Elect Director: Louis Sullivan | 34,414,900 | 3,233,844 | 38,108 | -- | 899,233 | Majority: yes |
| Elect Director: Tommy Thompson | 36,267,757 | 1,393,314 | 25,781 | -- | 899,233 | Majority: yes |
| Proposal 2: An advisory resolution to approve executive compensation: | 35,662,995 | 1,974,530 | 49,327 | -- | 899,233 | Majority: yes |
| Proposal 3: Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan: | 32,982,705 | 4,663,248 | 40,899 | -- | 899,233 | Majority: yes |
| Proposal 4: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024: | 37,189,791 | 1,373,453 | 22,841 | -- | -- | Majority: yes |
This meeting is also recorded here as 2024-06-27; both records come from the same filing, so the date should be checked against it.
Source: UNITED THERAPEUTICS CORP., Form 8-K — read the filing on EDGAR.
Each item below shows how the 546 asset managers that disclosed a UNITED THERAPEUTICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held 2024-06-26.
Combines 12 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 2: An advisory resolution to approve executive compensation:”): 35,662,995 for, 1,974,530 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 81% for, 4% against (85% of the company cast a for/against vote).
The 541 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,090,929 | 0 | 0 | 0 | For |
| BlackRock | 3,862,396 | 293 | 0 | 0 | For |
| Wellington | 2,893,649 | 0 | 0 | 0 | For |
| State Street | 2,353,665 | 0 | 0 | 0 | For |
| Fidelity | 2,165,758 | 0 | 0 | 0 | For |
| Renaissance | 1,865,644 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 828,609 | 0 | 0 | 0 | For |
| Charles Schwab | 797,770 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 797,860 | 0 | 0 | Against |
| Janus Henderson | 633,328 | 0 | 0 | 0 | For |
| AQR | 630,943 | 0 | 0 | 0 | For |
| Invesco | 614,872 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 566,134 | 0 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Dimensional | 516,746 | 0 | 0 | 0 | For |
| Nuveen | 512,631 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 464,493 | 19,070 | 0 | 0 | For |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 470,897 | 0 | 0 | 0 | For |
| AllianceBernstein | 463,252 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 450,970 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 431,171 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 411,955 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 409,587 | 0 | 0 | 0 | For |
| TIAA | 402,711 | 0 | 0 | 0 | For |
Showing the 25 largest of 541 asset managers. See all 541 in the interactive database.
Meeting held 2024-06-26.
Combines 5 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 3: Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan:”): 32,982,705 for, 4,663,248 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 75% for, 11% against (85% of the company cast a for/against vote).
The 145 asset managers below cast 92% of the shares they voted on this item FOR (14,942,761 for, 1,340,776 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 496,384 | 0 | 0 | Against |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 266,914 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 252,720 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Summit Street Capital Management, LLC | 90,039 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
Showing the 25 largest of 145 asset managers. See all 145 in the interactive database.
Meeting held 2024-06-26.
Combines 5 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 32,655,777 for, 5,007,451 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 74% for, 11% against (85% of the company cast a for/against vote).
The 134 asset managers below cast 91% of the shares they voted on this item FOR (14,281,204 for, 1,348,573 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 0 | 402,649 | 0 | 0 | Against |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 10,496 | 106,133 | 0 | 0 | Against |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 35,282 | 2,292 | 20,314 | 0 | For |
Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.
Meeting held 2024-06-26.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 4: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024:”): 37,189,791 for, 1,373,453 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).
The 134 asset managers below cast 99.6% of the shares they voted on this item FOR (15,581,660 for, 48,117 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,112 | 85 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 35,282 | 2,292 | 20,314 | 0 | For |
Showing the 25 largest of 134 asset managers. See all 134 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 33,657,384 for, 4,005,882 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 76% for, 9% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 96% of the shares they voted on this item FOR (14,913,322 for, 701,955 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 37,494,516 for, 166,925 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 85% for, 0.4% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 100% of the shares they voted on this item FOR (15,615,277 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,197 | 0 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 37,346,987 for, 314,603 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 84% for, 0.8% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99.9% of the shares they voted on this item FOR (15,607,619 for, 7,658 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,197 | 0 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 37,281,239 for, 380,261 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 84% for, 0.9% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99.9% of the shares they voted on this item FOR (15,607,619 for, 7,658 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,197 | 0 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 34,414,900 for, 3,233,844 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 78% for, 7% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 96% of the shares they voted on this item FOR (14,913,760 for, 701,517 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 35,207,735 for, 2,456,733 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 80% for, 6% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99.5% of the shares they voted on this item FOR (15,548,279 for, 66,998 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,112 | 85 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 36,692,631 for, 968,800 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 83% for, 2% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99.8% of the shares they voted on this item FOR (15,594,018 for, 21,259 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,197 | 0 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 34,881,879 for, 2,780,367 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 79% for, 6% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 96% of the shares they voted on this item FOR (14,932,213 for, 683,064 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 34,539,331 for, 3,124,020 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 78% for, 7% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 96% of the shares they voted on this item FOR (14,913,760 for, 701,517 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 1,123 | 610,074 | 0 | 0 | Against |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 35,926,944 for, 1,735,495 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 81% for, 4% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99.6% of the shares they voted on this item FOR (15,568,163 for, 47,114 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,112 | 85 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 80,302 | 0 | 0 | 0 | For |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 67,270 | 0 | 0 | 0 | For |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2024-06-26.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 36,267,757 for, 1,393,314 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 82% for, 3% against (85% of the company cast a for/against vote).
The 133 asset managers below cast 99% of the shares they voted on this item FOR (15,390,452 for, 224,825 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,021,620 | 0 | 0 | 0 | For |
| BlackRock | 1,892,675 | 0 | 0 | 0 | For |
| Fidelity | 1,352,480 | 0 | 0 | 0 | For |
| State Street | 611,112 | 85 | 0 | 0 | For |
| Capitol Series Trust | 542,642 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 496,384 | 0 | 0 | 0 | For |
| TIAA | 402,649 | 0 | 0 | 0 | For |
| Charles Schwab | 397,417 | 0 | 0 | 0 | For |
| Dimensional | 353,241 | 0 | 0 | 0 | For |
| Hartford | 343,796 | 0 | 0 | 0 | For |
| First Trust | 308,069 | 0 | 0 | 0 | For |
| Invesco | 292,664 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 196,574 | 0 | 0 | 0 | For |
| John Hancock | 159,558 | 0 | 0 | 0 | For |
| SEI | 126,310 | 0 | 0 | 0 | For |
| AQR | 117,429 | 0 | 0 | 0 | For |
| Jackson National | 116,629 | 0 | 0 | 0 | For |
| Principal | 82,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 82,048 | 0 | 0 | 0 | For |
| Equitable | 22,331 | 57,971 | 0 | 0 | Against |
| Prudential/PGIM | 71,177 | 0 | 0 | 0 | For |
| JPMorgan | 67,323 | 0 | 0 | 0 | For |
| AB RELATIVE VALUE FUND, INC. | 0 | 67,270 | 0 | 0 | Against |
| Northwestern Mutual | 61,954 | 0 | 0 | 0 | For |
| Brighthouse | 37,574 | 0 | 20,314 | 0 | For |
Showing the 25 largest of 133 asset managers. See all 133 in the interactive database.
Meeting held 2025-06-26 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
UNITED THERAPEUTICS CORP.’s own tally for this item (“Proposal 2: An advisory resolution to approve executive compensation:”): 38,413,776 for, 1,763,712 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 44,204,517 outstanding shares: 87% for, 4% against (91% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,958 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Weil Company, Inc. | 3,923 | 0 | 0 | 0 | For |
| Freedom Day Solutions, LLC | 35 | 0 | 0 | 0 | For |
Ranked by the number of UNITED THERAPEUTICS CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 44,204,517 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 13.78% |
| 2 | BlackRock | 8.74% |
| 3 | Wellington | 6.55% |
| 4 | State Street | 5.32% |
| 5 | Fidelity | 4.90% |
| 6 | Renaissance | 4.22% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.87% |
| 8 | Charles Schwab | 1.81% |
| 9 | Man Group plc | 1.80% |
| 10 | Janus Henderson | 1.43% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 12.11% | 13F |
| Vanguard Group | 10.00% | 13F |
| Martine Rothblatt | 7.98% | DEF14A |
| Wellington Management | 7.72% | 13F |
| Avoro Capital Advisors LLC | 6.47% | DEF14A |
| FMR LLC | 5.25% | DEF14A |
| Renaissance Technologies | 4.87% | 13F |
| State Street | 4.38% | 13F |
| Michael Benkowitz | 1.86% | DEF14A |
| James Edgemond | 1.48% | DEF14A |
Percentages above are of 44,204,517 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At UNITED THERAPEUTICS CORP.'s shareholder meeting held 2024-06-26, in the 2023-2024 proxy season, 546 asset managers reported how they voted on 16 ballot items in their SEC Form N-PX filings, covering 9,435 separate fund positions. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.